V020-2212 Screening compound: 4-[6-(benzenesulfonyl)-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine

V020-2212 Screening compound: 4-[6-(benzenesulfonyl)-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine
V020-2212 Screening compound: 4-[6-(benzenesulfonyl)-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-2212
4-[6-(benzenesulfonyl)-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-2212

Molecular Formula

C22H29N5O3S (C22 H29 N5 O3 S)

Compound Name

4-[6-(benzenesulfonyl)-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]morpholine

IUPAC name

4-[6-(benzenesulfonyl)-2-(piperidin-1-yl)-5H6H7H8H-pyrido[43-d]pyrimidin-4-yl]morpholine

SMILES

O=S(c1ccccc1)(N1Cc2c(N3CCOCC3)nc(N3CCCCC3)nc2CC1)=O

InChI

InChI=1S/C22H29N5O3S/c28-31(29,18-7-3-1-4-8-18)27-12-9-20-19(17-27)21(25-13-15-30-16-14-25)24-22(23-20)26-10-5-2-6-11-26/h1,3-4,7-8H,2,5-6,9-17H2

InChI Key

IVHSUUOCUWIVBH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19908858

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

443.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.463

Distribution Coefficient, logD

3.435

Water Solubility, LogSw

-3.65

Polar Surface Area

65.357

Acid Dissociation Constant (pKa)

20.31

Base Dissociation Constant (pKb)

10.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.50

V020-2212 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • GPCR
  • Kinases
  • Others
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with V020-2212 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-2212?
Check Price and Availability of V020-2212, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-2212 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-2212
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-2212
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-2212 available by request